semaglutide gastroparesis treatment People using popular drugs for weight loss, diabetes are more likely to be diagnosed with stomach paralysis, studies confirm Understanding gastroparesis and weight loss

The risk of gastroparesis has prompted surgeons to recommend stopping GLP-1 RAs before certain procedures

Development and manufacturing GMP scale-up of a continuous ir-catalyzed homogeneous reductive amination reaction

BMI percent based upon z-score correlated well with baseline fat mass (correlation = 0.475, p = 0.0004)

Predictive factors of polycystic ovary syndrome in girls with precocious pubarche

[13] The combination of NSAID cardiovascular risk with an elevated-cardiovascular-risk patient population on semaglutide represents a clinically significant concern that warrants careful individualized assessment

Aspen Pharmacare, a South African drugmaker, plans to enter the Canadian market with a generic version of Novo Nordisks blockbuster diabetes and weight-loss drug Ozempic by the third quarter of 2026